Low Molecular Hearing Loss Agent via Parameter Changes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current solutions for preventing or improving hearing loss are either costly or lack effectiveness in addressing various causes such as inner ear dysfunction, drug-induced hearing loss, noise-induced hearing loss, and age-related hearing loss.
Innovation Solution
A low molecular weight compound group, represented by specific formulas (I0, II, and III), is used as an active ingredient in an agent to prevent or improve hearing loss, which can be administered orally or as a pharmaceutical composition, targeting inner ear, nerve, noise, aging, and oxidative stress-related hearing issues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing agents for preventing or improving hearing loss are used, then hearing loss can be addressed, but they are costly and lack effectiveness for various causes
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of existing compounds to create new derivatives with improved therapeutic effects. Specifically, the invention modifies compounds of formula (I) by changing substituent parameters (R1, R2, R3 groups) to generate a series of derivatives that exhibit enhanced ability to prevent and improve hearing loss across multiple etiologies including noise-induced, drug-induced, and age-related hearing loss, while maintaining cost-effectiveness
Solution Approach 2:
The patent achieves universality by developing a compound that addresses multiple causes of hearing loss simultaneously. The compound of formula (I) and its derivatives demonstrate broad-spectrum efficacy against noise-induced hearing loss, drug-induced hearing loss (such as cisplatin and gentamicin toxicity), age-related hearing loss, and oxidative stress-related hearing impairment, making it a multi-functional agent that replaces the need for multiple specialized treatments
2Ease of manufacture
If existing agents for preventing or improving hearing loss are used, then hearing loss can be addressed, but they are not easily producible
Solution Approach 1:
The patent applies segmentation by breaking down the complex molecular structure into modular components that can be systematically varied. The compound of formula (I) is segmented into core structure and variable substituent groups (R1, R2, R3), allowing for systematic synthesis of derivatives through standardized chemical reactions. This modular approach simplifies the production process while enabling optimization of therapeutic effectiveness across different hearing loss conditions
Data Source
AI summary
It is to provide an agent for preventing or improving hearing loss, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient. One or more compounds selected from the group consisting of compounds represented by the following formulas (I0), (II), and (III) and a pharmaceutically acceptable salt of the compounds when R3 is OH are used as an agent for preventing or improving hearing loss.